Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    xp23829
Show Display Options
Rank Status Study
1 Completed A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis
Condition: Psoriasis
Interventions: Drug: XP23829 400 mg QD;   Drug: XP 23829 800 mg QD;   Drug: XP23829 400 mg BID;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.